Last week Arizona based Insys Therapeutics donated $500 million USD to anti-legalization group Arizonans for Responsible Drug Policy. This is the largest single contribution to any anti-legalization group ever.
Up until Insys’ donation, the legalization movement in Arizona had out-raised opponents of legalization by a 3 to 1 ratio, with the group The Campaign to regulate Marijuana Like Alcohol raising 3 million for the legalization effort in the state.
Insys is known for making the powerful and dangerous opiate Subsys Fentanyl, aka Fentanyl, and is currently under federal investigation for improper marketing of Fentanyl to physicians. Insys also recently developed a drug that synthesizes the effects of THC called Syndros, which was approved by the FDA to treat cancer and AIDS patients.
In a statement Insys said that they did not support the legalization measure in Arizona, called Prop 205 because, “it fails to protect the safety of Arizona’s citizens, and particularly its children.”
They went on to say, “Insys firmly believes in the potential clinical benefits of cannabinoids. Like many in the healthcare community, we hope that patients will have the opportunity to benefit from these potential products once clinical trials demonstrate their safe and effective use.”
Of course Insys’ interest in keeping cannabis illegal appears suspect to many people. “It appears they are trying to kill a non-pharmaceutical market for marijuana in order to line their own pockets,” said legalization proponent J.P. Holyoak in a statement.
Insys states that they believe cannabis treatments can be beneficial, yet they continue to fight against it, despite the fact that there is plenty of scientific evidence in favor of cannabis. How can their motivations appear to be anything but financial?
What are your thoughts on pharmaceutical companies fighting legalization? Share in the comments!